Skip to search formSkip to main contentSkip to account menu

NSC-26271

Known as: NSC 26271, NSC26271 
National Institutes of Health

Related topics

Related topics

3 relations
Altretamine/cisplatin/cyclophosphamide/doxorubicin protocolB-518

Broader (1)

Cyclophosphamide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1976
1976
Combination chemotherapy with adriamycin (NSC-123127) and cyclophosphamide (NSC-26271) for solid tumors: a phase II trial.
One hundred and nine adult patients with metastatic carcinoma were treated at 3-4-week intervas with a combination of adriamycin… 
1976
1976
Methotrexate (NSC-740) with citrovorum factor (NSC-3590) rescue, alone and in combination with cyclophosphamide (NSC-26271), in ovarian cancer.
: In a randomized study, 35 patients with advanced-stage epithelial ovarian cancers with progressive disease after prior single… 
1976
1976
Some studies on the distribution and effects of cyclophosphamide (NSC-26271) in normal and neoplastic tissue.
The gross uptake and intracellula distribution of 32P-cyclophosphamide has been studied in normal and neoplastic rat and mouse… 
1976
1976
Studies on 4-hydroperoxycyclophosphamide (NSC-181815): a simple preparation method and its application for the synthesis of a new class of "activated" sulfur-containing cyclophosphamide (NSC-26271…
4-Hydroperoxycyclophosphamide was obtained in approximately 20% yield by ozonization of cyclophosphamide in acetone/water at 0… 
1976
1976
Permeation of cyclophosphamide (NSC-26271) metabolites into tumor cells.
The permeation kinetics of cyclophosphamide and its metabolites were studied with Ehrlich ascites tumor cells, murine L1210… 
1976
1976
Importance of pharmacokinetic studies on cyclophosphamide (NSC-26271) in understanding its cytotoxic effect.
Pharmacokinetic studies on cyclophosphamide (CP) and its alkylating metabolites produced by hepatic biotransformation have been… 
1976
1976
Studies on the selective action of cyclophosphamide (NSC-26271): Inactivation of the hydroxylated metabolite by tissue-soluble enzymes.
The hypothesis that selective action of cyclophosphamide, compared to other nitrogen mustards, is due to a balance between… 
1975
1975
Remission maintenance of acute nonlymphoblastic leukemia with BCNU (NSC-409962) and cyclophosphamide (NSC-26271).
Thirteen of 29 patients with acute nonlymphoblastic leukemia achieved complete remission with cyclophosphamide, cytosine… 
1975
1975
Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in combination with cyclophosphamide (NSC-26271) in the treatment of human malignancies.
: The effectiveness of cis-dichlorodiammineplatinum(II) in the treatment of human malignancies is evaluated. The first stage of… 
Highly Cited
1972
Highly Cited
1972
Cyclophosphamide (NSC-26271), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) (COAP) combination chemotherapy for acute leukemia in adults.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)